However, absent additional guidance, we believe that hospitals have the capability to report this market-based data, as required, for cost reporting periods ending on or after January 1, 2026
The study was retrospective, relied on structured EHR data, and used coded definitions for recurrence rather than centrally adjudicated oncologic outcomes
Exploring the Variety within GLP-1 Medications: Its important to recognize that while Ozempic is a widely recognized GLP-1 receptor agonist, other notable medications in this class include Victoza (liraglutide), Trulicity (dulaglutide), Bydureon (exenatide extended-release), and Rybelsus (oral semaglutide)
When lifestyle changes fail to deliver results, modern medical treatments can help you regain control
It incorporates affective mapping tools and spatial narrative techniques, integrating affective data from social surveys with spatial data through Public Participation GIS (PPGIS)[5]